Identificación de acciones de salud en el programa de control de sífilis en gestantes, Cartagena de Indias, 2016.
Identificación de acciones de salud en el programa de control de sífilis en gestantes, Cartagena de Indias, 2016.
NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.
Furthermore, the authors keep their property intellectual rights over the articles.
Show authors biography
Basis: Congenital Syphilis is an infection caused by the hematogenous spread of Treponema pallidum from the pregnant woman infected to the fetus. At the time of pregnancy, control of the disease during pregnancy is vital in prenatal care. Objective: To identify the fulfillment of the health actions included in the Syphilis Control Program in pregnant women of the city of Cartagena de Indias, first half of 2016. Materials and methods: Cross-sectional descriptive observational study. A total of 781 prenatal control pregnant women were evaluated in the city, through the institutions that provide health services (PHI) and health promotion companies (PHE). Results: Gestation was completed in 358 (45.8%) of the pregnant women studied. In 25 (6.5%) of the total, intrapartum VDRL was not performed. During the first trimester of pregnancy 99.6% of the resulting non-reactive VDRL (NR) evaluations. While in the II quarter they were evaluated, 67.5% and 57.4%, respectively; resulting reactive VDRL (R) one (0.1%) during both semesters. From the II to the III semester of pregnancy, the number of pregnant women was not increased (98, 12.5%) and (63, 8, 1%), however, if it increased (55, 19.8%) (269; 34.4 %), respectively, pregnant women who are waiting for the time to perform the test. There is no co-infection Syphilis / HIV / AIDS. Conclusions: The control of syphilis during prenatal care was deficient given the high rate of non-adherence in the compliance of the treatment in the pregnant woman, as the realization was not made according to the time by the health team Of the test.
Article visits 360 | PDF visits 163
Downloads
[1] A. A. Wahab, U. K. Ali, and M. Mohammad, “Syphilis in pregnancy,” Pakistan J. Med. Sci., vol. 31, no. 1, pp. 2014–2016, 2014.
[2] M. Magalhães, L. Basto, A. Luísa, M. Eulália, and A. Paulo, “Syphilis in Pregnancy and Congenital Syphilis : Reality in a Portuguese Central University Hospital,” Rev. Bras. Gineoobstetricia, vol. 39, no. 6, 2017.
[3] World Health Organization, Infecciones de Transmision Sexual 2016–2021. Geneva, Switzerland., 2016, pp. 5–64.
[4] I. N. de Salud, Protocolo de Vigilancia en Salud Pública: Sifilis gestacional y Sifilis congenita. Colombia, 2015, pp. 2–40.
[5] OPS, Guía clínica para la eliminación de la transmisión materno infantil del VIH y de la sífilis congénita en América Latina y el Caribe. USA,Washington D.C., 2009, pp. 1–100.
[6] M. de S. de Colombia, Guía de práctica clínica ( GPC ) basada en la evidencia para la atención integral de la sífilis gestacional y congénita. Colombia, 2014, pp. 3–25.
[7] M. De Santis et al., “Syphilis Infection during Pregnancy : Fetal Risks and Clinical Management,” Infect. Dis. Obstet. Gynecol., vol. 2012, pp. 3–5, 2012.
[8] J. E. Stoltey, S. E. Cohen, S. Francisco, and S. Francisco, “Syphilis transmission : a review of the current evidence,” Sex Heal., vol. 12, no. 2, pp. 103–109, 2018.
[9] R. E. Plotzker, R. D. Murphy, and J. E. Stoltey, “Congenital Syphilis Prevention : Strategies , Evidence , and Future Directions,” Sex. Transm. Dis., vol. 45, no. 9, pp. 29–37, 2018.
[10] M. de S. de Colombia, Plan de Intensificacion para la Eliminacion de la Sifilis Congenita. Colombia, 2016, pp. 6–10.
[11] R. Creasy, Robert K. Resnik, Creasy and Resnik’s Maternal-Fetal Medicine, 7th ed. Philadelphia, 2014.
[12] J. S. Slutsker, R. R. Hennessy, and J. A. Schillinger, “Factors Contributing to Congenital Syphilis Cases — New York City , 2010 – 2016,” MMWR Morb Mortal Wkly Report., vol. 67, no. 39, pp. 1088–1093, 2018.
[13] W. J. Ledger, “Syphilis in pregnancy Review,” Br. Med. J., vol. 76, no. 2, pp. 73–79, 2000.
[14] S. J. Hawkes, G. B. Gomez, and N. Broutet, “Early Antenatal Care : Does It Make a Difference to Outcomes of Pregnancy Associated with Syphilis ? A Systematic Review and Meta-Analysis,” PLoS One, vol. 8, no. 2, 2013.
[15] W. H. Organization, Syphilis screening and treatment for pregnant women. Geneva, Switzerland, 2017.
[16] M. L. Kamb et al., “A Road Map for the Global Elimination of Congenital Syphilis,” Obs. Gynecol Int., vol. 2010, pp. 1–6, 2010.
[17] L. . Herrera,Vivian. Rodríguez, “Incidencia de la sífilis durante el embarazo,” Rev. Cuba. Med. Gen. Integr., vol. 13, no. 4, pp. 352–358, 1997.
[18] C. Padovani, R. R. De Oliveira, and S. M. Pelloso, “Syphilis in during pregnancy : association of maternal and perinatal characteristics in a region of southern Brazil 1,” 2018.
[19] F. ValderramaI,Julia. Zacarías, “Maternal syphilis and congenital syphilis in Latin America: big problem, simple solution,” Rev. Panam. salud publica, vol. 16, no. 4, pp. 211–217, 2004.
Information
Keywords
